INDICATIONS AND PBS INFORMATION
MOVICOL® is indicated for the relief of constipation and the treatment of chronic constipation.
MOVICOL® is also the only oral medication indicated and currently available in pharmacies for the treatment of faecal impaction.
MOVICOL®-Half, and MOVICOL® Junior, are indicated for effective treatment of constipation, chronic constipation and faecal impaction in children. MOVICOL®-Half and MOVICOL® Junior are the only oral medications indicated and currently available in pharmacies for the treatment of faecal impaction in children aged 2–11 years.
Please note MOVICOL®-Half and MOVICOL® Junior can also be used in adults who need a smaller dose.
MOVICOL® Adult 30 sachets includes MOVICOL® (Lemon-Lime flavour), MOVICOL Flavour Free and MOVICOL® Chocolate flavour. All flavours are interchangeable on the PBS.
PBS RESTRICTED BENEFIT
Restricted benefit, 1+5 repeats
Chronic constipation or faecal impaction not adequately controlled with first line interventions such as bulk forming agents
Constipation in patients with malignant neoplasia
Paraplegic and quadriplegic patients and others with severe neurogenic impairment of bowel function not responding to other oral therapies
Patients receiving palliative care
PBS AUTHORITY - PALLIATIVE CARE
Initial supply (for up to 4 months) for palliative care patients where constipation is a problem (2+3 repeats)
Continuing supply for a palliative care patient where constipation is a problem (2+0 repeats)